In 2020, I was a subject in the Moderna phase III trial for their COVID mRNA vaccine. At the same time, Pfizer-BioNTec trialed a similar mRNA vaccine. Both mRNA vaccines proved highly successful. In both cases, chemically modified mRNA encoding the SARS-CoV-2 spike protein is injected, programming cells that receive the mRNA to produce and secrete spike protein until the mRNA decays.Now, a innovative self-amplifying mRNA vaccine has been approved in Japan has been developed that requires far less modified mRNA:“Self-amplifying mRNA vaccines contain a gene that encodes the spike protein as well as viral genes that code for replicase, the enzyme that serves as a photocopier. So one self-amplifying mRNA molecule can produce many more.”This
Topics:
Joel Eissenberg considers the following as important: COVID vaccines, Healthcare, Hot Topics, self-amplifying mRNA vaccine
This could be interesting, too:
Angry Bear writes The Ageing Population
Bill Haskell writes Are Drug Companies Alone Responsible for the Prices We Pay for Medicines?
Bill Haskell writes Firearm Violence Is a Public Health Crisis
NewDealdemocrat writes New Deal democrat’s Weekly Indicators July 15 – 19 2024
In 2020, I was a subject in the Moderna phase III trial for their COVID mRNA vaccine. At the same time, Pfizer-BioNTec trialed a similar mRNA vaccine. Both mRNA vaccines proved highly successful. In both cases, chemically modified mRNA encoding the SARS-CoV-2 spike protein is injected, programming cells that receive the mRNA to produce and secrete spike protein until the mRNA decays.
Now, a innovative self-amplifying mRNA vaccine has been approved in Japan has been developed that requires far less modified mRNA:
“Self-amplifying mRNA vaccines contain a gene that encodes the spike protein as well as viral genes that code for replicase, the enzyme that serves as a photocopier. So one self-amplifying mRNA molecule can produce many more.”
This self-amplifying mRNA proved to be more effective than the Pfizer-BioNTec vaccine in eliciting a high-titer antibody response.
One concern I have is that the expression of the viral replicase will elicit a T-cell-mediated immune response that will block booster injections by killing cells that express the replicase proteins.
Stephanie Arnett/Mittr | ENVATO